| 1071 |
CEFICAD 1000 |
CEFEPIME HYDROCHLORIDE USP EQ.TO CEFEPIME 1000 MG (STERILE MIXTURE OF CEFEPIME HCL AND L-ARGININE) |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
PNEUMONIA (MODERATE TO SEVERE), EMPIRIC THERAPY FOR FIBRILE NEUTROPENIC PATIENTS, UNCOMPLICATED AND COMPLICATED URINARY TRACT INFECTION (INCLUDING PYELONEPHRITIS), UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTION, COMPLICATED INTRA-ABDOMINAL INFECTION. |
No |
IC Pharma Lao Co., Ltd |
CADILA PHARMACEUTICALS LIMITED |
INDIA |
CERTIFICATE RELEASED |
03 I 5400/23 |
2023-03-17 |
2026-03-16 |
View |
| 1072 |
DOMPERON |
DOMPERIDONE BP 1 MG/ML |
ORAL SUSPENSION |
BOTTLE |
FOR THE RELIEF OF THE SYMPTOMS OF NAUSEA AND VOMITING |
Yes |
IC Pharma Lao Co., Ltd |
CADILA PHARMACEUTICALS LIMITED |
INDIA |
CERTIFICATE RELEASED |
03 I 5401/23 |
2023-03-17 |
2026-03-16 |
View |
| 1073 |
FLUCORT-N SKIN |
FLUOCINOLONE ACETONIDE 0.025%, NEOMYCIN SULPHATE 0.5% |
CREAM |
TUBE |
ATOPIC ECZEMA,
PSORIASIS, SEBORRHOEIC DERMATITIS, CONTACT DERMATITIS, NEURODERMATITIS, LUPUS
ERYTHEMATOUS, ERYTHEMA MULTIFORME, PYODERMATITIS, IMPETIGO, OTITIS EXTERNA,
ANO-GENITAL AND SENILE PRURITUS
|
No |
IC Pharma Lao Co., Ltd |
GLENMARK PHARMACEUTICALS LIMITED |
INDIA |
CERTIFICATE RELEASED |
06 I 2587/05 |
2024-01-08 |
2027-01-07 |
View |
| 1074 |
GATISON EYE DROP |
GATIFLOXACIN EQ.TO ANHYDROUS GATIFLOXACIN 0.3% W/V |
OPHTHALMIC SOLUTION |
VIAL |
FOR THE TREATMENT OF PATIENTS 1 YEAR OF AGE AND OLDER WITH BACTERIAL CONJUNCTIVITIS CAUSED BY SUSCEPTIBLE STRAINS OF THE FOLLOWING BACTERIA: STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS EPIDERMIDIS, STREPTOCOCCUS PNEUMONIAE, HAEMOPHILUS INFLUENZAE |
No |
IC Pharma Lao Co., Ltd |
ARGON REMEDIES PVT.LTD |
INDIA |
CERTIFICATE RELEASED |
09 I 5806/24 |
2024-09-25 |
2029-09-24 |
View |
| 1075 |
GENSERRA 10 MG |
SERRATIOPEPTIDASE 10 MG |
TABLET |
BLISTERPACK |
POST-OPREATIVE EDEMA AND HEMATOMA, REMISSION OF SWELLING AFTER SURGICAL STITCHING, RESOLUTION OF TISSUE DRAINAGE, EASE IN POST ANESTHETIC SPUTUM EXPECTORATION |
No |
IC Pharma Lao Co., Ltd |
RESCUERS LIFE SCIENCES LTD |
INDIA |
CERTIFICATE RELEASED |
08 I 4777/19 |
2023-06-07 |
2026-06-06 |
View |
| 1076 |
IC - GATE EYE DROPS |
GATIFLOXACIN SESQUIHYDRATE USP EQ. TO GATIFLOXACIN 0.3% W/V
|
EYE DROPS |
BOTTE |
TREATMENT OF BACTERIAL CONJUNCTIVITIS CAUSED BY SUSCEPTIBLE STRAINS OF THE FOLLOWING AEROBIC GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIA SUCH AS S.AUREUS, S. EPIDERMIDIS, S. PNEUMONIAE, S. MITIS, COMYEBACTERIUM PROPINQUULM AND HAEMOPHILLUS INFLUENZA. |
No |
IC Pharma Lao Co., Ltd |
HEALTH BIOTECH LTD |
INDIA |
CERTIFICATE RELEASED |
10 I 4288/17 |
2023-04-28 |
2026-04-27 |
View |
| 1077 |
KETOPLUS |
KETOCONAZOLE BP 2% W/V, ZINC PYRITHIONE (ZPTO) 1% W/V |
SHAMPOO |
BOTTLE |
FOR USE IN THE TREATMENT OF DANDRUFF AND SEBORRHOEIC DERMATITIS OF SCALP |
No |
IC Pharma Lao Co., Ltd |
GLENMARK PHARMACEUTICALS LIMITED |
INDIA |
CERTIFICATE RELEASED |
05 I 2555/05 |
2024-01-08 |
2027-01-07 |
View |
| 1078 |
LORFAST 10 |
LORATADINE USP 10 MG |
TABLET |
ALU-ALU BLISTER |
FOR THE SYMPTOMATIC TREATMENT OF ALLERGIC RHINITIS AND CHRONIC IDIOPATHIC URTICARIA |
No |
IC Pharma Lao Co., Ltd |
CADILA PHARMACEUTICALS LIMITED |
INDIA |
CERTIFICATE RELEASED |
03 I 5402/23 |
2023-03-17 |
2026-03-16 |
View |
| 1079 |
LOSIUM 50 |
LOSARTAN POTASSIUM USP 50 MG |
FILM COATED TABLET |
ALU/PVC/PVDC- BLISTER |
TREATMENT OF ESSENTIAL HYPERTENSION IN ADULTS AND IN CHILDREN AND ADOLESCENTS 6 -18 YEARS OF AGE, TREATMENT OF CHRONIC HEART FAILURE IN ADULT PATIENT. |
Yes |
IC Pharma Lao Co., Ltd |
CADILA PHARMACEUTICALS LIMITED |
INDIA |
CERTIFICATE RELEASED |
03 I 5403/23 |
2023-03-17 |
2026-03-16 |
View |
| 1080 |
MUMFER CHEWABLE TABLET |
IRON (III) HYDROXIDE POLYMALTOSE COMPLEX EQ.TO ELEMENTAL IRON 100MG, FOLIC ACID BP 500 MCG |
CHEWABLE TABLET |
ALU STRIP |
PROPHYLAXIS AND TREATMENT OF IRON- DEFICIENCY ANAEMIAS SUCH AS HYPOCHROMIC ANAEMIA ASSOCIATED WITH PREGNANCY AND LACTATION, CHRONIC OR ACUTE BLOOD LOSS, DIETARY RESTRICTION, METABOLIC DISEASE AND POST SURGICAL CCONVALESCENCE… |
Yes |
IC Pharma Lao Co., Ltd |
GLENMARK PHARMACEUTICALS LIMITED |
INDIA |
CERTIFICATE RELEASED |
02 I 2752/06 |
2024-01-08 |
2027-01-07 |
View |
